Pancreatic Cancer Research

ResearcherShenzhen UniversityActive in the last 2 years

Feifan Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8213-507X; OpenAlex author ID A5021081534. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 5

  1. A Near-Infrared-II Antibody-Photosensitizer Conjugate for Photoimmunotherapy of Advanced Pancreatic Cancer. Co-author DOI 10.1021/acsnano.6c11768↗
  2. Synergistic interventional photothermal therapy and immunotherapy using an iron oxide nanoplatform for the treatment of pancreatic cancer. Co-author DOI 10.1016/j.actbio.2021.10.048↗
  3. Label-free whole-colony imaging and metabolic analysis of metastatic pancreatic cancer by an autoregulating flexible optical system. Co-author DOI 10.7150/thno.40869↗
  4. Local Phototherapy Synergizes with Immunoadjuvant for Treatment of Pancreatic Cancer through Induced Immunogenic Tumor Vaccine. Co-author DOI 10.1158/1078-0432.ccr-18-1126↗
  5. Photothermal Effects of Reduced Graphene Oxide on Pancreatic Cancer. Last author DOI 10.1177/1533034618768637↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dingyuan Yan · 1 shared paper, 2026 · strength 0.32
  2. Ben Zhong Tang · 1 shared paper, 2026 · strength 0.32
  3. Wei R. Chen · 2 shared papers, 2018–2022 · strength 0.24
  4. Meng Wang · 1 shared paper, 2022 · strength 0.15
  5. Priyabrata Mukherjee · 1 shared paper, 2022 · strength 0.15
  6. Binglin Shen · 1 shared paper, 2020 · strength 0.12
  7. Liwei Liu · 1 shared paper, 2020 · strength 0.12
  8. Jie Wu · 1 shared paper, 2018 · strength 0.11
  9. Jingxuan Yang · 1 shared paper, 2018 · strength 0.09
  10. Mingyang Liu · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.